Huron Consulting Group Announces New Managing Directors
Experts Join Company's Pharmaceutical and Performance Improvement Teams
CHICAGO - April 26, 2006 - Huron Consulting Group (NASDAQ: HURN), a leading provider of financial and operational consulting services, today announced that Mark A. DeWyngaert, Gary T. Long, and Paul J. Silver will join the Company as managing directors.
"Huron Consulting Group continues to expand its footprint in the pharmaceutical, medical device, and biotech sector. And our Performance Improvement practice is helping companies across industries improve the bottom line," said Gary E. Holdren, chairman and chief executive officer, Huron Consulting Group. "In joining these growth practices, Mark, Gary and Paul will have significant opportunity to build professional strength and our company's market presence. We welcome them and know that their depth of experience will be invaluable to our clients."
Dr. DeWyngaert, managing director in Huron's Pharmaceuticals and Health Plans practice, specializes in assisting pharmaceutical manufacturers, biotechnology, and medical device companies identify and mitigate regulatory risks and value intellectual property. He trained as a molecular biologist and has been actively involved with industry in both research and business development roles for the past 25 years. DeWyngaert has provided operational, clinical, managerial, consulting, and litigation services to various segments of the healthcare industry. He is a frequent speaker on the management of regulatory risks associated with promotional, education, research and clinical development activities; as well as, in valuation practices and intellectual property matters. He comes to Huron from Ernst & Young LLP's Health Sciences Group. DeWyngaert received his PhD, MA, and BA from the University of Rochester and his MBA from New York University. He will be based in Huron's New York office.
Long, managing director in Huron's Performance Improvement practice, has extensive experience in the planning, development, execution, and management of supply chain and performance improvement solutions with major corporations both domestically and internationally. He works with clients to optimize performance and profitability by coordinating and leveraging organizational resources. Long joins Huron from Accenture, Inc., where he was a partner in the Global Supply Chain practice. He has also held senior roles at A.T. Kearney, Inc. Long received his MBA from the University of New Haven and his BS from Fairfield University. He will be based in Huron's New York office.
Silver, managing director in Huron's Pharmaceuticals and Health Plans practice, specializes in healthcare compliance and regulatory matters in the pharmaceutical, medical device, and pharmacy industries. With more than 18 years of experience in the pharmaceutical industry, he brings a unique perspective on the issues and challenges these organizations face to meet both compliance and business objectives. Silver comes to Huron from Ernst & Young LLP where he was a director and senior member of the Fraud Investigation & Dispute Services practice. He was also member of their Global Pharmaceutical Industry leadership team. Prior to joining Ernst & Young, Silver held various operations and sales and marketing roles at two multi-national pharmaceutical manufacturers. He is also a nationally recognized speaker in the area of pharmaceutical compliance. Silver received his BS in Business Finance and Communications from the University of Alabama. He will be based in Atlanta.
About Huron Consulting Group
Huron Consulting Group helps clients effectively address complex challenges that arise from litigation, disputes, investigations, regulation, financial distress, and other sources of significant conflict or change. We also help clients improve the overall efficiency and effectiveness of their operations, reduce costs, manage regulatory compliance, and maximize procurement efficiency. Huron provides services to a wide variety of both financially sound and distressed organizations, including Fortune 500 companies, medium-sized businesses, leading academic institutions, healthcare organizations, and the law firms that represent these various organizations. Learn more at www.huronconsultinggroup.com.
Jennifer Frost Hennagir, Director
P (312) 880-3260
F (312) 583-8701